Roivant Sciences Ltd. (ROIV) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2026 | -$515.07M | +48.7% |
| 2025 | -$1.00B | -122.3% |
| 2024 | $4.50B | +595.9% |
| 2023 | -$906.76M | +32.9% |
| 2022 | -$1.35B | -26.2% |
| 2021 | -$1.07B | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2026 | -$515.07M | +48.7% |
| 2025 | -$1.00B | -122.3% |
| 2024 | $4.50B | +595.9% |
| 2023 | -$906.76M | +32.9% |
| 2022 | -$1.35B | -26.2% |
| 2021 | -$1.07B | — |